Ville Pettila
Overview
Explore the profile of Ville Pettila including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
246
Citations
8364
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Serlo M, Inkinen N, Lakkisto P, Valkonen M, Pulkkinen A, Selander T, et al.
Sci Rep
. 2024 Sep;
14(1):20808.
PMID: 39242877
Fluid therapy is a fundamental part of supportive therapy in critical care. However, it is also a suspected risk for endothelial glycocalyx degradation which is associated with poor clinical outcomes....
2.
Pickkers P, Angus D, Bass K, Bellomo R, van den Berg E, Bernholz J, et al.
Intensive Care Med
. 2024 Mar;
50(4):614-615.
PMID: 38436728
No abstract available.
3.
Vaara S, Serpa Neto A, Bellomo R, Adhikari N, Dreyfuss D, Gallagher M, et al.
Crit Care Explor
. 2024 Feb;
6(2):e1053.
PMID: 38380940
Objectives: Among patients with severe acute kidney injury (AKI) admitted to the ICU in high-income countries, regional practice variations for fluid balance (FB) management, timing, and choice of renal replacement...
4.
Pickkers P, Angus D, Bass K, Bellomo R, van den Berg E, Bernholz J, et al.
Intensive Care Med
. 2024 Jan;
50(1):68-78.
PMID: 38172296
Purpose: Ilofotase alfa is a human recombinant alkaline phosphatase with reno-protective effects that showed improved survival and reduced Major Adverse Kidney Events by 90 days (MAKE90) in sepsis-associated acute kidney...
5.
Wald R, Gaudry S, da Costa B, Adhikari N, Bellomo R, Du B, et al.
Intensive Care Med
. 2023 Oct;
49(11):1305-1316.
PMID: 37815560
Background: There is controversy regarding the optimal renal-replacement therapy (RRT) modality for critically ill patients with acute kidney injury (AKI). Methods: We conducted a secondary analysis of the STandard versus...
6.
Lauren E, Sankkila L, Pettila V, Kerkela E
Transfus Med Hemother
. 2023 Jul;
50(3):208-217.
PMID: 37434997
Introduction: Red blood cell (RBC) transfusion may affect the recipient immune system. During RBC storage in an unphysiological environment, RBC quality and function are impaired, the cells bleb extracellular vesicles...
7.
Francois B, Lambden S, Fivez T, Gibot S, Derive M, Grouin J, et al.
Lancet Respir Med
. 2023 Jun;
11(10):894-904.
PMID: 37269870
Background: Activation of the triggering receptor expressed on myeloid cells-1 (TREM-1) pathway is associated with septic shock outcomes. Data suggest that modulation of this pathway in patients with activated TREM-1...
8.
Wihersaari L, Reinikainen M, Tiainen M, Bendel S, Kaukonen K, Vaahersalo J, et al.
Acta Anaesthesiol Scand
. 2023 Apr;
67(7):964-971.
PMID: 37118921
Background: We studied the prognostic ability of serum ubiquitin C-terminal hydrolase L1 (UCH-L1) after out-of-hospital cardiac arrest (OHCA), compared to that of neuron-specific enolase (NSE). Methods: In this post-hoc analysis...
9.
Pickkers P, Angus D, Arend J, Bellomo R, van den Berg E, Bernholz J, et al.
BMJ Open
. 2023 Apr;
13(4):e065613.
PMID: 37012016
Introduction: Sepsis, the leading cause of acute kidney injury (AKI), is associated with a high morbidity and mortality. Alkaline phosphatase (ALP) is an endogenous detoxifying enzyme. A recombinant human ALP...
10.
Inkinen N, Pettila V, Valkonen M, Serlo M, Backlund M, Hastbacka J, et al.
Crit Care
. 2022 Dec;
26(1):401.
PMID: 36550559
Background: Fluid bolus therapy is a common intervention to improve urine output. Data concerning the effect of a fluid bolus on oliguria originate mainly from observational studies and remain controversial...